CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-09 | Wong Ryan Ho-Yan Chief Financial Officer | Shares withheld for taxes | −113 | $16.95 | $2K | 135,320 |
| 2026-03-09 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −484 | $16.95 | $8K | 138,864 |
| 2026-03-09 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −346 | $16.95 | $6K | 138,518 |
| 2026-03-09 | Rodino-Klapac Louise President, R&D and Tech Ops | Shares withheld for taxes | −504 | $16.95 | $9K | 227,166 |
| 2026-03-09 | Rodino-Klapac Louise President, R&D and Tech Ops | Shares withheld for taxes | −895 | $16.95 | $15K | 226,271 |
| 2026-03-09 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −1,036 | $16.95 | $18K | 203,663 |
| 2026-03-09 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −583 | $16.95 | $10K | 203,080 |
| 2026-03-02 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −408 | $16.20 | $7K | 139,348 |
| 2026-03-02 | Wong Ryan Ho-Yan Chief Financial Officer | Shares withheld for taxes | −450 | $16.20 | $7K | 135,595 |
| 2026-03-02 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −3,301 | $16.20 | $53K | 205,574 |
| 2026-03-02 | Estepan Ian Michael Chief Operating Officer | Shares withheld for taxes | −875 | $16.20 | $14K | 204,699 |
| 2026-03-02 | Rodino-Klapac Louise President, R&D and Tech Ops | Shares withheld for taxes | −3,718 | $16.20 | $60K | 228,437 |
| 2026-03-02 | Rodino-Klapac Louise President, R&D and Tech Ops | Shares withheld for taxes | −767 | $16.20 | $12K | 227,670 |
| 2026-03-01 | Estepan Ian Michael Chief Operating Officer | Option exercise | +8,125 | 208,875 | ||
| 2026-03-01 | Estepan Ian Michael Chief Operating Officer | Option exercise · Performance Stock Units | −8,125 | 0 | ||
| 2026-03-01 | Rodino-Klapac Louise President, R&D and Tech Ops | Option exercise | +8,125 | 232,155 | ||
| 2026-03-01 | Rodino-Klapac Louise President, R&D and Tech Ops | Option exercise · Performance Stock Units | −8,125 | 0 | ||
| 2026-02-26 | Estepan Ian Michael Chief Operating Officer | Option exercise | +2,069 | $13.71 | $28K | 195,369 |
| 2026-02-26 | Estepan Ian Michael Chief Operating Officer | Option exercise | +5,381 | $13.71 | $74K | 200,750 |
| 2026-02-26 | Estepan Ian Michael Chief Operating Officer | Option exercise · Stock Option (right to buy) | −2,069 | 0 |
Page 2 of 12 · 227 trades